Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08)-Reference-Cited by-同舟云学术

Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08)

Published:2019-04-16 Issue:10 Volume:120 Page:968-974
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Curioni-Fontecedro Alessandra, ,Perentes Jean Yannis,Gelpke Hans,Xyrafas Alexandros,Bouchaab Hasna,Mach Nicolas,Matzinger Oscar,Stojcheva Nina,Frueh Martin,Weder Walter,Cathomas Richard,Gargiulo Piera,Bubendorf Lukas,Pless Miklos,Betticher Daniel,Peters Solange

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s41416-019-0447-0.pdf

Reference34 articles.

1. Goldstraw, P., Chansky, K., Crowley, J., Rami-Porta, R., Asamura, H., Eberhardt, W. E. et al. The IASLC Lung Cancer Staging Project: Proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer. J. Thorac. Oncol. 11, 39–51 (2016).

2. Peters, S., Weder, W., Dafni, U., Kerr, K. M., Bubendorf, L., Meldgaard, P. et al. Lungscape: resected non-small-cell lung cancer outcome by clinical and pathological parameters. J. Thorac. Oncol. 9, 1675–1684 (2014).

3. Albain, K. S., Rusch, V. W., Crowley, J. J., Rice, T. W., Turrisi, A. T. 3rd, Weick JK et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J. Clin. Oncol. 13, 1880–1892 (1995).

4. Stupp, R., Mayer, M., Kann, R., Weder, W., Zouhair, A., Betticher, D. C. et al. Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial. Lancet Oncol. 10, 785–793 (2009).

5. Grunenwald, D. H., Andre, F., Le Pechoux, C., Girard, P., Lamer, C., Laplanche, A. et al. Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 122, 796–802 (2001).

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NK cells and the profile of inflammatory cytokines in the peripheral blood of patients with advanced carcinomas;Cytokine;2024-02

2. Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms;Pneumologie;2023-10

3. Extended resection for potentially operable patients with stage III non–small cell lung cancer after induction treatment;The Journal of Thoracic and Cardiovascular Surgery;2022-12

4. Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials;ESMO Open;2022-04

5. Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer;Nature Reviews Clinical Oncology;2021-04-28